Showing results (951-960 of 3,505) with videos related to
Sort By:
Pageof 351
Frontiers in Bioscience (Landmark Edition)|January 29, 2022
Penetrating cardiac injuries: literature review and analysis of the forensic approachMichela Ferrara, Benedetta Baldari, Simona Vittorio, et al.Frontiers in Bioscience (Landmark Edition)|January 29, 2022
Isoform-specific and cell/tissue-dependent effects of p38 MAPKs in regulating inflammation and inflammation-associated oncogenesisJian-Zhong Qin, Hong Xin, Xiao-Mei Qi, et al.Frontiers in Bioscience (Landmark Edition)|November 1, 2021
Interaction of anti-diabetic medications and gut microbiotaRu Chen, Sheng PanFrontiers in Bioscience (Landmark Edition)|November 1, 2021
Characterization of multiscale logic operations in the neural circuitsJunHyuk Woo, Kiri Choi, Soon Ho Kim, et al.Frontiers in Bioscience (Landmark Edition)|November 1, 2021
The biological effect of cobalt chloride mimetic-hypoxia on nucleus pulposus cells and the comparability with physical hypoxia in vitroXiao-Xin Gao, Chen-Hao Liu, Zhi-Lei Hu, et al.Frontiers in Bioscience (Landmark Edition)|November 1, 2021
Tropism and transduction of oncolytic adenovirus vectors in prostate cancer therapyChuang Wu, Fu-Kun Wei, Zi-Yang Xu, et al.Frontiers in Bioscience (Landmark Edition)|November 1, 2021
Approaches for the amelioration of adverse effects of drought stress on crop plantsAnamika Dubey, Ashwani Kumar, Muneer Ahmad Malla, et al.Frontiers in Bioscience (Landmark Edition)|July 22, 2022
Selenium Concentration in Cattle Serum and Fodder from Two Areas in Ethiopia with Contrasting Human Selenium ConcentrationKaleab Hailu, Dawd Gashu, Edward J M Joy, et al.Frontiers in Bioscience (Landmark Edition)|July 22, 2022
Trafficking and Gating Cooperation Between Deficient Nav1.5-mutant Channels to Rescue INaJérôme Clatot, Alain Coulombe, Isabelle Deschênes, et al.Frontiers in Bioscience (Landmark Edition)|July 22, 2022
The "SEED" Study: The Feasibility of Selecting Patient-Specific Biologically Targeted Therapy with Sorafenib, Everolimus, Erlotinib or Dasatinib for Pediatric and Young Adult Patients with Recurrent or Refractory Brain TumorsBonnie L Cole, Kimberly Starr, Christina M Lockwood, et al.Pageof 351